$1,411,827 awarded to research since 1985
Schizophrenia is a serious mental illness that inhibits a person’s ability to think clearly, recognize reality, interact with others, and manage emotions. Symptoms can include hallucinations, delusions, hearing voices, flat emotional expression, and disorganized or obsessive thinking. While the disease isn’t common, it still affects 3.2 million Americans, and can have devastating consequences for a sufferer’s ability to keep a job or maintain interpersonal relationships. Despite its relative lack of prevalence, its severity and high mortality rate makes schizophrenia the Foundation’s second most highly funded area of study, after depression.
Investigating Brain and Behavior Development in Typical and High-Risk Children Award: $46,921 Mental illnesses are likely present early in childhood, long before the symptoms begin to emerge in adolescence or adulthood. By leveraging the [...]
Establishing Network Targets during Development for Non-Invasive Brain Stimulation Award: $37,549 There is some evidence to suggest that directly stimulating the brain with a targeted, low-level electrical current may yield positive effects on certain [...]
Randomized controlled trial of pyridoxine for tardive dyskinesia Award: $99,900 To date, the only effective medications to treat the symptoms associated with schizophrenia are the “antipsychotic” class of medications. Unfortunately, these medications have many [...]